Substance Use Disorder & Abuse Liability Services
A thorough assessment of abuse liability is a critical part of the non-clinical safety evaluation of any new compound that directly or indirectly targets the central nervous system. Transpharmation provides all required in vivo pharmacology services for abuse liability assessment in support of the regulatory submission of novel compounds. In addition, Transpharmation provides efficacy testing aimed at evaluating whether a novel compound is effective in reducing the reinforcing, motivational, and adverse effects of known drugs of abuse.